` ECS (ECS Botanics Holdings Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

ECS
vs
S
S&P/ASX 300

Over the past 12 months, ECS has underperformed S&P/ASX 300, delivering a return of -38% compared to S&P/ASX 300's 3% drop.

Stocks Performance
ECS vs S&P/ASX 300

Loading...
ECS
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ECS vs S&P/ASX 300

Loading...
ECS
S&P/ASX 300
Difference
www.alphaspread.com

Performance By Year
ECS vs S&P/ASX 300

Loading...
ECS
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
ECS Botanics Holdings Ltd vs Peers

S&P/ASX 300
ECS
LLY
JNJ
MRK
NOVN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

ECS Botanics Holdings Ltd
Glance View

Market Cap
8m AUD
Industry
Pharmaceuticals

ECS Botanics Holdings Ltd. manufactures, supplies and retails cannabis products. The firm utilizes progressive and cultivation methodologies to produce medicine in a sustainable way, adopting regenerative and organic horticultural practices and renewable energy sources. The firm is a producer and supplier of affordable, premium-grade medicinal cannabis. The firm services both the Australian market and key international markets. The company specializes in cultivating cannabis, which after drying and curing, is supplied as a trimmed flower for inhalation, or extracted into resin for further formulation or manufacturing.

ECS Intrinsic Value
AU$0.044
Undervaluation 89%
Intrinsic Value
Price AU$0.005
Back to Top